Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for Marimed (MRMD) over the last 12 years, with Q2 2025 value amounting to $2.0 million.

  • Marimed's Long-Term Debt Issuances changed N/A to $2.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 7196.9%. This contributed to the annual value of $1.2 million for FY2024, which is 9600.34% down from last year.
  • Marimed's Long-Term Debt Issuances amounted to $2.0 million in Q2 2025.
  • In the past 5 years, Marimed's Long-Term Debt Issuances registered a high of $29.1 million during Q1 2023, and its lowest value of $1.2 million during Q1 2024.
  • Moreover, its 5-year median value for Long-Term Debt Issuances was $2.7 million (2021), whereas its average is $7.6 million.
  • In the last 5 years, Marimed's Long-Term Debt Issuances soared by 1257.04% in 2022 and then plummeted by 9600.34% in 2024.
  • Quarter analysis of 5 years shows Marimed's Long-Term Debt Issuances stood at $2.7 million in 2021, then grew by 12.57% to $3.0 million in 2022, then soared by 870.0% to $29.1 million in 2023, then crashed by 96.0% to $1.2 million in 2024, then skyrocketed by 71.97% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q2 2025, $1.2 million for Q1 2024, and $29.1 million during Q1 2023.